| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/01/2012 | US20120053073 Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids |
| 03/01/2012 | US20120053071 Method for the detection of dna methylation patterns |
| 03/01/2012 | US20120053069 Determination of a Genotype of an Amplification Product at Multiple Allelic Sites |
| 03/01/2012 | US20120053068 Real-time pcr of targets on a micro-array |
| 03/01/2012 | US20120053066 Methods for predicting esophageal adenocarcinoma (eac) |
| 03/01/2012 | US20120052528 Method for producing selective medium and use thereof |
| 03/01/2012 | US20120052527 Laboratory method and experimental specimen for validating the efficacy of antimicrobial agents on bovine carcasses |
| 03/01/2012 | US20120052526 Tissue Infiltration Method |
| 03/01/2012 | US20120052525 Polymers for growing cells |
| 03/01/2012 | US20120052524 Cell evaluation system using cell sheet and method for using the system |
| 03/01/2012 | US20120052523 Devices and methods for observing the cell division |
| 03/01/2012 | US20120052522 Apparatus And Method For The Study Of Metabolism |
| 03/01/2012 | US20120052521 Sheath flow device and method |
| 03/01/2012 | US20120052520 Methods, compositions and a kit suitable for determining the concentration of gamma-hydroxy butyric acid (ghb) in a sample |
| 03/01/2012 | US20120052519 Methods for assaying alpha-l-iduronidase enzymatic activity |
| 03/01/2012 | US20120052518 Fluorescent probe for measuring protease |
| 03/01/2012 | US20120052517 Methods for testing an immune response using cultures of t cells, b cells and dendritic cells |
| 03/01/2012 | US20120052515 Therapeutic applications of noncovalent dimerizing antibodies |
| 03/01/2012 | US20120052510 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 03/01/2012 | US20120052509 Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment |
| 03/01/2012 | US20120052508 Genetic markers and diagnostic methods for resistance of breast cancer to hormonal therapies |
| 03/01/2012 | US20120052507 Phospholinked dye analogs with an amino acid linker |
| 03/01/2012 | US20120052506 Cyanine dyes |
| 03/01/2012 | US20120052505 Methods for detecting embryonic stem cells, induced pluripotent stem cells, or cells undergoing reprogramming to produce induced pluripotent stem cells |
| 03/01/2012 | US20120052504 Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease |
| 03/01/2012 | US20120052503 Kit for detecting neisseria gonorrhoeae strains and method for detecting neisseria gonorrhoeae strains using the same |
| 03/01/2012 | US20120052502 Real-time pcr detection using stabilized probes |
| 03/01/2012 | US20120052501 Kit for detecting htlv strains and use thereof |
| 03/01/2012 | US20120052500 Kit for detecting chlamydia trachomatis strains and method for detecting chlamydia trachomatis strains using the same |
| 03/01/2012 | US20120052499 Methods For Whole-Cell Analysis Of Gram-Positive Bacteria |
| 03/01/2012 | US20120052498 Detection of Nucleic Acids |
| 03/01/2012 | US20120052497 Method of simultaneously amplifying target sequences from salmonella spp. and e. coli o157:h7 and kit therefor |
| 03/01/2012 | US20120052496 Compositions, kits and methods for detection of campylobacter nucleic acid |
| 03/01/2012 | US20120052495 Oligonucleotides for detecting listeria monocytogenes and use thereof |
| 03/01/2012 | US20120052494 OLIGONUCLEOTIDES FOR DETECTING E. coli O157:H7 STRAINS AND USE THEREOF |
| 03/01/2012 | US20120052493 Oligonucleotides for detecting listeria spp. and use thereof |
| 03/01/2012 | US20120052492 Oligonucleotides for detecting listeria spp. and use thereof |
| 03/01/2012 | US20120052491 Cell analyzer and cell analyzation method |
| 03/01/2012 | US20120052490 Methods and systems for monitoring reactions |
| 03/01/2012 | US20120052489 Methods and compositions for sequencing nucleic acids using charge |
| 03/01/2012 | US20120052488 Photodamage mitigation compounds and systems |
| 03/01/2012 | US20120052487 Methods and compositions for selecting sirna of improved functionality |
| 03/01/2012 | US20120052486 Identification of high grade or >= cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers |
| 03/01/2012 | US20120052485 Sperm separation system |
| 03/01/2012 | US20120052484 Methods of diagnosing cervical cancer |
| 03/01/2012 | US20120052483 Kit for detecting hiv-1 and method for detecting hiv-1 using the same |
| 03/01/2012 | US20120052482 Kit for detecting hepatitis c virus and method of detecting hepatitis c virus using the same |
| 03/01/2012 | US20120052481 Assays for detecting modified compounds |
| 03/01/2012 | US20120052091 Potomac horse fever isolates |
| 03/01/2012 | US20120052079 Compositions, Kits, and Methods for Predicting Anti-Cancer Response to Anthracyclines |
| 03/01/2012 | US20120052071 Tumor markers and methods of use thereof |
| 03/01/2012 | US20120052066 Markers and methods for assessing and treating lupus patients susceptible to photoprovocation |
| 03/01/2012 | US20120052059 Regulatory b cells and their use |
| 03/01/2012 | US20120052057 method for selecting responders to blockade of integrin receptors |
| 03/01/2012 | US20120052051 Method of treating diabetes - related vascular complications |
| 03/01/2012 | US20120052048 Antibacterial phage, phage peptides and methods of use thereof |
| 03/01/2012 | US20120052006 Gold/lanthanide nanoparticle conjugates and uses thereof |
| 03/01/2012 | DE102010048899B3 Verfahren zum Diagnostizieren aneuploider kolorektaler Tumore A method for diagnosing aneuploid colorectal tumors |
| 03/01/2012 | DE102010038330A1 Verfahren, Vorrichtung und Testkit für Molekularbiologische Reaktionen Method, device and test kit for molecular biological reactions |
| 03/01/2012 | CA2847151A1 Cell characterisation |
| 03/01/2012 | CA2809498A1 Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on sirpa expression |
| 03/01/2012 | CA2809342A1 Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr) |
| 03/01/2012 | CA2809308A1 Assays for detecting modified compounds |
| 03/01/2012 | CA2809085A1 Enzymatic reagent inks for use in test strips having a predetermined calibration code |
| 03/01/2012 | CA2809055A1 Defining diagnostic and therapeutic targets of conserved free floating fetal dna in maternal circulating blood |
| 03/01/2012 | CA2808539A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases |
| 03/01/2012 | CA2808227A1 Antimicrobial method for fermentation processes |
| 03/01/2012 | CA2807823A1 Methods for predicting anti-cancer response |
| 03/01/2012 | CA2807505A1 Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same |
| 03/01/2012 | CA2807244A1 A novel diagnostic and therapeutic target in inflammatory and/or cardiovascular diseases |
| 03/01/2012 | CA2803693A1 Methods for nucleic acid capture and sequencing |
| 02/29/2012 | EP2423335A2 Chimeric immunomodulatory compounds and methods of using the same |
| 02/29/2012 | EP2423334A2 Non-invasive fetal genetic screening by digital analysis |
| 02/29/2012 | EP2423333A1 Prognostic markers and therapeutic targets for lung cancer |
| 02/29/2012 | EP2423332A1 Prognostic markers and therapeutic targets for lung cancer |
| 02/29/2012 | EP2423331A2 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| 02/29/2012 | EP2423330A1 Method of prognosing recurrence of prostate cancer |
| 02/29/2012 | EP2423329A1 Method of prognosing recurrence of prostate cancer |
| 02/29/2012 | EP2423327A2 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 02/29/2012 | EP2423326A2 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 02/29/2012 | EP2423325A1 Method of preparing libraries of template polynucleotides |
| 02/29/2012 | EP2423324A1 Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation |
| 02/29/2012 | EP2423323A1 Method for evaluating cancer |
| 02/29/2012 | EP2423322A1 Hybridization probes for nucleic acid detection, universal stems, methods and kits |
| 02/29/2012 | EP2423321A2 Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers |
| 02/29/2012 | EP2423310A1 Cancer antigen helper peptide |
| 02/29/2012 | EP2423302A1 New serum-free medium for inducing pluripotent stem cells quickly with high efficiency and method using thereof |
| 02/29/2012 | EP2423216A1 Replication competent hepatitis C virus and methods of use |
| 02/29/2012 | EP2421994A2 Bin1 as a prognostic marker in cardiovascular disease |
| 02/29/2012 | EP2421993A1 Biological specimen collection/transport compositions and methods |
| 02/29/2012 | EP2421992A1 Hp1alpha as a prognostic marker in human cancer |
| 02/29/2012 | EP2421991A1 Breast cancer susceptibility gene gt198 and uses thereof |
| 02/29/2012 | EP2421990A1 Compositions for use in security marking |
| 02/29/2012 | EP2421989A1 Cellular assay employing detectable protein |
| 02/29/2012 | EP2421988A2 Method of diagnosing bladder cancer |
| 02/29/2012 | EP2421987A1 Use of methylation status of mint loci as a marker for rectal cancer |
| 02/29/2012 | EP2421969A2 Selective detection of bordetella species |
| 02/29/2012 | EP2421955A1 Methods for obtaining fetal genetic material |
| 02/29/2012 | EP2421883A1 Trapping compounds and method for identifying reactive metabolites |
| 02/29/2012 | EP2421881A1 Engineered demeter 5-methylcytosine dna glycosylase with improved yield, stability and solubility |